Income Statement Healthlead

Stocks

HL

THA598010009

Drug Retailers

End-of-day quote Thailand S.E. 2026-08-20			5-day change	1st Jan Change
5.100 ^THB	-4.67%		-6.42%	-29.17%

08-17	Healthlead Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-10	Healthlead Public Company Limited (SET:HL) announces an Equity Buyback for 6,000,000 shares, representing 2.21% for THB 42 million.	CI

e35d.45djkf2-5gLv_f0zeI4Yc0hDD7eDVadM8LErgCeZzKc.zu1O-avPgjeOjKlbGfkoRCUZSIPGZOp9ieNf6RLXgZeI-ijatujLYKycjg

Published financial data: HEALTHLEAD

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	1.2B	1.52B	1.64B	1.98B	2.23B
Other Revenues, Total	17.62M	18.69M	23.77M	34.35M	41.07M
Total Revenues	1.22B	1.54B	1.66B	2.01B	2.27B
Cost of Goods Sold, Total	922M	1.14B	1.26B	1.51B	1.69B
Gross Profit	294M	395M	401M	499M	583M
Selling General & Admin Expenses, Total	191M	250M	307M	410M	481M
Other Operating Expenses	-	-2.97M	-6.68M	-6.33M	-7.93M
Other Operating Expenses, Total	191M	247M	300M	404M	473M
Operating Income	103M	148M	101M	95.39M	111M
Interest Expense, Total	-5.34M	-5.73M	-8.98M	-13.61M	-16.59M
Interest And Investment Income	41.94K	166K	2.87M	8.02M	4.68M
Net Interest Expenses	-5.3M	-5.56M	-6.12M	-5.59M	-11.91M
Other Non Operating Income (Expenses)	-	-	-	210K	-165K
EBT, Excl. Unusual Items	97.35M	143M	94.61M	90M	98.5M
Gain (Loss) On Sale Of Assets	-	-	-	6.45M	-
Asset Writedown	-	-	-571K	-	-
EBT, Incl. Unusual Items	97.35M	143M	94.04M	96.46M	98.5M
Income Tax Expense	17.68M	24.61M	19.36M	18.19M	20.64M
Earnings From Continuing Operations	79.66M	118M	74.68M	78.26M	77.86M
Net Income to Company	79.66M	118M	74.68M	78.26M	77.86M
Net Income - (IS)	79.66M	118M	74.68M	78.26M	77.86M
Net Income to Common Incl Extra Items	79.66M	118M	74.68M	78.26M	77.86M
Net Income to Common Excl. Extra Items	79.66M	118M	74.68M	78.26M	77.86M
Per Share Items
Net EPS - Basic	0.39	0.43	0.27	0.29	0.29
Basic EPS - Continuing Operations	0.39	0.43	0.27	0.29	0.29
Basic Weighted Average Shares Outstanding	206M	272M	272M	272M	268M
Net EPS - Diluted	0.39	0.43	0.27	0.29	0.29
Diluted EPS - Continuing Operations	0.39	0.43	0.27	0.29	0.29
Diluted Weighted Average Shares Outstanding	206M	272M	272M	272M	268M
Normalized Basic EPS	0.29	0.33	0.22	0.21	0.23
Normalized Diluted EPS	0.29	0.33	0.22	0.21	0.23
Dividend Per Share	0.28	0.18	0.15	0.17	0.22
Payout Ratio	47.7	36.81	65.56	52.13	59.39
Supplemental Items
EBITDA	117M	163M	126M	131M	153M
EBITA	103M	148M	101M	95.39M	113M
EBIT	103M	148M	101M	95.39M	111M
EBITDAR	118M	-	-	-	-
Total Revenues (As Reported)	1.22B	1.54B	1.66B	2.02B	2.27B
Effective Tax Rate - (Ratio)	18.16	17.23	20.58	18.86	20.95
Current Domestic Taxes	-	-	-	20.45M	21.98M
Total Current Taxes	17.58M	25.88M	19.17M	20.45M	21.98M
Deferred Domestic Taxes	-	-	-	-2.26M	-1.35M
Total Deferred Taxes	97.34K	-1.28M	183K	-2.26M	-1.35M
Normalized Net Income	60.84M	89.27M	59.13M	56.25M	61.56M
Interest on Long-Term Debt	4.93M	-	-	-	-
Non-Cash Pension Expense	56.69K	82.53K	98.52K	126K	124K
Supplemental Operating Expense Items
Selling and Marketing Expenses	124M	171M	230M	325M	391M
General and Administrative Expenses	67.27M	78.79M	76.5M	85.01M	89.72M
Net Rental Expense, Total	748K	-	-	-	-
Imputed Operating Lease Interest Expense	245K	-	-	-	-
Imputed Operating Lease Depreciation	503K	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	705M	146M	335M	169M	37.43M
Short Term Investments	4.48M	4.01M	65.12M	62.27M	74.96M
Trading Asset Securities, Total	-	503M	158M	286M	437M
Total Cash And Short Term Investments	709M	653M	558M	517M	549M
Accounts Receivable, Total	804K	1.68M	3.03M	3.65M	5.63M
Other Receivables	14.76M	22.66M	33.96M	39.72M	43.87M
Total Receivables	15.56M	24.33M	36.99M	43.37M	49.5M
Inventory	159M	210M	232M	291M	310M
Prepaid Expenses	1.34M	1.85M	2.18M	2.91M	3.35M
Other Current Assets, Total	1.36M	562K	19.23M	761K	772K
Total Current Assets	887M	890M	848M	854M	913M
Gross Property Plant And Equipment	258M	435M	591M	762M	852M
Accumulated Depreciation	-66.41M	-97.15M	-139M	-214M	-300M
Net Property Plant And Equipment	192M	338M	452M	549M	551M
Long-term Investments	-	-	29.76M	34.93M	7.1M
Goodwill	15.62M	15.62M	15.62M	15.62M	15.62M
Other Intangibles, Total	8.58M	7.81M	7.7M	9.85M	9.48M
Deferred Tax Assets Long-Term	1.03M	1.96M	1.69M	3.97M	5.89M
Other Long-Term Assets, Total	14.54M	34.92M	27.6M	31.87M	33.49M
Total Assets	1.12B	1.29B	1.38B	1.5B	1.54B
Liabilities
Accounts Payable, Total	107M	132M	-	137M	184M
Accrued Expenses, Total	8.22M	13.27M	14.32M	20.45M	23.09M
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	3.93M	-	-	-	-
Current Portion of Leases	12.37M	19.7M	25.35M	36.24M	44.67M
Current Income Taxes Payable	8.9M	14.75M	8.28M	10.29M	9.09M
Unearned Revenue Current, Total	352K	119K	85.44K	129K	1.2M
Other Current Liabilities	3.24M	7.46M	151M	6.93M	6.46M
Total Current Liabilities	144M	187M	199M	211M	269M
Long-Term Debt	308K	-	-	-	-
Long-Term Leases	101M	148M	199M	260M	274M
Pension & Other Post Retirement Benefits	4.96M	4.01M	4.54M	5.36M	7.44M
Deferred Tax Liability Non Current	-	-	-	94.26K	604K
Other Non Current Liabilities	1.26M	7.45M	11.56M	16.41M	17.83M
Total Liabilities	252M	346M	414M	493M	568M
Common Stock, Total	136M	136M	136M	136M	136M
Additional Paid In Capital	648M	648M	648M	648M	648M
Retained Earnings	60.1M	136M	162M	200M	231M
Treasury Stock	-	-	-	-	-69.58M
Comprehensive Income and Other	22.15M	22.15M	22.15M	22.15M	22.15M
Total Common Equity	866M	942M	968M	1.01B	968M
Total Equity	866M	942M	968M	1.01B	968M
Total Liabilities And Equity	1.12B	1.29B	1.38B	1.5B	1.54B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	272M	272M	272M	272M	262M
ECS Total Common Shares Outstanding	272M	272M	272M	272M	262M
Book Value / Share	3.18	3.46	3.56	3.7	3.7
Tangible Book Value	842M	919M	945M	980M	943M
Tangible Book Value Per Share	3.09	3.38	3.47	3.6	3.6
Total Debt	118M	167M	224M	296M	318M
Net Debt	-591M	-486M	-334M	-220M	-231M
Debt Equivalent of Unfunded Proj. Benefit Obligation	4.96M	4.01M	4.54M	5.36M	7.44M
Debt Equivalent Oper. Leases	5.99M	-	-	-	-
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	739K	1M	677K	447K	648K
Inventories - Finished Goods, Total	159M	210M	232M	291M	309M
Inventories - Others	-	-	-	-	-
Land - (BS)	8.18M	31.51M	30.7M	30.7M	30.7M
Buildings, Total	14.95M	132M	196M	242M	259M
Machinery, Total	28.6M	46.43M	69.88M	89.72M	101M
Full Time Employees	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	79.66M	118M	74.68M	78.26M	77.86M
Depreciation & Amortization - CF	29.75M	36.79M	54.58M	75.32M	90.75M
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	-	1.96M
Depreciation & Amortization, Total	29.75M	36.79M	54.58M	75.32M	92.71M
Amortization of Deferred Charges, Total - (CF)	1.18M	1.3M	1.45M	1.77M	-
(Gain) Loss From Sale Of Asset	66.24K	5.22K	116K	-6.41M	-202K
(Gain) Loss on Sale of Investments - (CF)	-	-2.97M	-6.68M	-6.33M	-7.93M
Asset Writedown & Restructuring Costs	-	-	571K	-210K	165K
Provision and Write-off of Bad Debts	-	-	-	-	-
Other Operating Activities, Total	6.86M	11.36M	1.93M	7.53M	11.39M
Change In Accounts Receivable	-2.91M	-2.89M	-11.05M	-9.47M	-9.1M
Change In Inventories	-28.97M	-51.92M	-21.73M	-58.71M	-18.33M
Change In Accounts Payable	9.89M	30M	7.04M	8.71M	47.89M
Change in Other Net Operating Assets	-10.37M	-3.72M	-9.65M	-1.7M	-1.23M
Cash from Operations	85.18M	136M	91.26M	88.76M	193M
Capital Expenditure	-12.81M	-120M	-81.54M	-74.56M	-32.19M
Sale of Property, Plant, and Equipment	20.57K	280	22.43K	9K	264K
Sale (Purchase) of Intangible assets	-2M	-535K	-1.33M	-3.92M	-1.01M
Investment in Marketable and Equity Securities, Total	-	-4.02M	-93.48M	-2.92M	14.5M
Other Investing Activities, Total	41.94K	-500M	354M	-90.5M	-139M
Cash from Investing	-14.75M	-625M	177M	-172M	-157M
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Short Term Debt Repaid, Total	-23.94M	-	-	-	-
Long-Term Debt Repaid, Total	-16.58M	-26.78M	-31.12M	-42.21M	-53.89M
Total Debt Repaid	-40.52M	-26.78M	-31.12M	-42.21M	-53.89M
Issuance of Common Stock	684M	-	-	-	-
Repurchase of Common Stock	-	-	-	-	-67.32M
Common Dividends Paid	-38M	-43.52M	-48.96M	-40.8M	-46.24M
Common & Preferred Stock Dividends Paid	-38M	-43.52M	-48.96M	-40.8M	-46.24M
Other Financing Activities, Total	-5.4M	-36.5K	-1.64K	-4.95K	-7.69K
Cash from Financing	600M	-70.34M	-80.08M	-83.01M	-167M
Net Change in Cash	670M	-559M	188M	-166M	-131M
Supplemental Items
Cash Interest Paid	5.4M	36.5K	1.64K	4.95K	7.69K
Cash Income Tax Paid (Refund)	17.76M	20.85M	24.68M	17.2M	23.19M
Levered Free Cash Flow	49.28M	-8.42M	-16.04M	3.08M	142M
Unlevered Free Cash Flow	52.61M	-4.84M	-10.43M	11.59M	152M
Change In Net Working Capital	27.67M	15.01M	46.54M	46.64M	-23.3M
Net Debt Issued / Repaid	-40.52M	-26.78M	-31.12M	-42.21M	-53.89M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	8.37	7.71	4.71	4.14	4.55
Return on Total Capital	10.13	8.86	5.47	4.78	5.34
Return On Equity %	15.83	13.08	7.82	7.93	7.89
Return on Common Equity	15.83	13.08	7.82	7.93	7.89
Margin Analysis
Gross Profit Margin %	24.17	25.68	24.17	24.81	25.71
SG&A Margin	15.73	16.22	18.5	20.39	21.18
EBITDA Margin %	9.63	10.59	7.61	6.53	6.76
EBITA Margin %	8.44	9.65	6.07	4.74	4.96
EBIT Margin %	8.44	9.65	6.07	4.74	4.87
Income From Continuing Operations Margin %	6.55	7.69	4.5	3.89	3.43
Net Income Margin %	6.55	7.69	4.5	3.89	3.43
Net Avail. For Common Margin %	6.55	7.69	4.5	3.89	3.43
Normalized Net Income Margin	5	5.8	3.56	2.8	2.71
Levered Free Cash Flow Margin	4.05	-0.55	-0.97	0.15	6.24
Unlevered Free Cash Flow Margin	4.33	-0.31	-0.63	0.58	6.69
Asset Turnover
Asset Turnover	1.59	1.28	1.24	1.4	1.5
Fixed Assets Turnover	6.33	5.81	4.2	4.02	4.13
Receivables Turnover (Average Receivables)	978.97	1.23K	694.96	591.75	480.44
Inventory Turnover (Average Inventory)	6.36	6.19	5.69	5.79	5.62
Short Term Liquidity
Current Ratio	6.14	4.76	4.26	4.05	3.4
Quick Ratio	5.02	3.62	2.99	2.65	2.23
Operating Cash Flow to Current Liabilities	0.59	0.73	0.46	0.42	0.72
Days Sales Outstanding (Average Receivables)	0.37	0.3	0.52	0.62	0.76
Days Outstanding Inventory (Average Inventory)	57.41	58.98	64.1	63.2	64.99
Average Days Payable Outstanding	38.73	36.56	-	31.86	34.37
Cash Conversion Cycle (Average Days)	19.06	22.72	-	31.97	31.38
Long Term Solvency
Total Debt/Equity	13.63	17.76	23.17	29.48	32.91
Total Debt / Total Capital	12	15.09	18.81	22.77	24.76
LT Debt/Equity	11.75	15.67	20.55	25.87	28.29
Long-Term Debt / Total Capital	10.34	13.31	16.69	19.98	21.29
Total Liabilities / Total Assets	22.57	26.87	29.97	32.9	37
EBIT / Interest Expense	19.23	25.92	11.21	7.01	6.66
EBITDA / Interest Expense	24.81	32.34	17.29	12.54	12.25
(EBITDA - Capex) / Interest Expense	22.41	11.36	8.21	7.06	10.31
Total Debt / EBITDA	0.89	0.9	1.44	1.74	1.57
Net Debt / EBITDA	-4.47	-2.62	-2.15	-1.29	-1.14
Total Debt / (EBITDA - Capex)	0.99	2.57	3.04	3.08	1.86
Net Debt / (EBITDA - Capex)	-4.95	-7.47	-4.52	-2.29	-1.35
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	12.63	26.46	7.87	21.22	12.85
Gross Profit, 1 Yr. Growth %	18.14	34.36	1.53	24.47	16.91
EBITDA, 1 Yr. Growth %	46.12	39.14	-22.48	3.94	16.87
EBITA, 1 Yr. Growth %	39.81	44.58	-32.13	-5.3	17.98
EBIT, 1 Yr. Growth %	39.81	44.58	-32.13	-5.3	15.92
Earnings From Cont. Operations, 1 Yr. Growth %	52.98	48.41	-36.84	4.8	-0.52
Net Income, 1 Yr. Growth %	52.98	48.41	-36.84	4.8	-0.52
Normalized Net Income, 1 Yr. Growth %	46.31	46.73	-33.77	-4.29	9.44
Diluted EPS Before Extra, 1 Yr. Growth %	20.02	12.57	-36.84	4.8	0.79
Accounts Receivable, 1 Yr. Growth %	-51.15	108.41	80.98	20.41	54.17
Inventory, 1 Yr. Growth %	21.58	32.07	10.18	25.46	6.63
Net Property, Plant and Equip., 1 Yr. Growth %	-0.61	76.2	33.92	21.35	0.54
Total Assets, 1 Yr. Growth %	170.24	15.19	7.31	8.44	2.46
Tangible Book Value, 1 Yr. Growth %	615.56	9.13	2.85	3.77	-3.86
Common Equity, 1 Yr. Growth %	515.91	8.79	2.77	3.9	-3.8
Cash From Operations, 1 Yr. Growth %	-12.15	59.77	-33	-2.75	117.72
Capital Expenditures, 1 Yr. Growth %	-4.46	838.16	-32.13	-8.56	-56.82
Levered Free Cash Flow, 1 Yr. Growth %	-20.22	-119.16	90.49	-119.19	4.5K
Unlevered Free Cash Flow, 1 Yr. Growth %	-20.44	-110.24	115.33	-211.09	1.21K
Dividend Per Share, 1 Yr. Growth %	300	-35.71	-16.67	13.33	29.41
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	14.06	19.34	16.8	14.35	16.96
Gross Profit, 2 Yr. CAGR %	-43.93	25.99	16.79	12.42	20.63
EBITDA, 2 Yr. CAGR %	57.26	42.59	3.85	-10.24	10.22
EBITA, 2 Yr. CAGR %	78.27	42.17	-0.94	-19.83	5.7
EBIT, 2 Yr. CAGR %	78.27	42.17	-0.94	-19.83	4.78
Earnings From Cont. Operations, 2 Yr. CAGR %	91.31	50.68	-3.18	-18.64	2.11
Net Income, 2 Yr. CAGR %	91.31	50.68	-3.18	-18.64	2.11
Normalized Net Income, 2 Yr. CAGR %	84.09	46.52	-1.42	-20.62	2.35
Diluted EPS Before Extra, 2 Yr. CAGR %	68.48	16.23	-15.68	-18.64	2.78
Accounts Receivable, 2 Yr. CAGR %	-51.88	0.9	94.21	47.62	36.25
Inventory, 2 Yr. CAGR %	7.05	26.72	20.63	17.57	15.66
Net Property, Plant and Equip., 2 Yr. CAGR %	65.84	32.33	53.61	27.48	10.45
Total Assets, 2 Yr. CAGR %	94.18	76.44	11.18	7.87	5.41
Tangible Book Value, 2 Yr. CAGR %	208.41	179.45	5.94	3.31	-0.12
Common Equity, 2 Yr. CAGR %	183.03	158.85	5.73	3.33	-0.02
Cash From Operations, 2 Yr. CAGR %	-	18.52	3.47	-19.28	45.51
Capital Expenditures, 2 Yr. CAGR %	-	199.38	152.34	-21.22	-37.17
Levered Free Cash Flow, 2 Yr. CAGR %	-	-63.07	-39.59	-39.54	197.03
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-72.94	-53.04	54.67	281.65
Dividend Per Share, 2 Yr. CAGR %	-	60.36	-26.81	-2.82	21.11
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	15.42	18.05	15.39	18.25	13.85
Gross Profit, 3 Yr. CAGR %	25.77	-24.97	17.24	19.3	13.89
EBITDA, 3 Yr. CAGR %	71.06	50.97	16.37	3.88	-1.98
EBITA, 3 Yr. CAGR %	114.94	66.25	11.12	-2.41	-8.81
EBIT, 3 Yr. CAGR %	130.92	66.25	11.12	-2.41	-9.34
Earnings From Cont. Operations, 3 Yr. CAGR %	489.23	75.78	12.77	-0.59	-13
Net Income, 3 Yr. CAGR %	489.23	75.78	12.77	-0.59	-13
Normalized Net Income, 3 Yr. CAGR %	234.45	70.68	12.45	-2.58	-11.65
Diluted EPS Before Extra, 3 Yr. CAGR %	441.42	47.29	-5.15	-9.34	-12.62
Accounts Receivable, 3 Yr. CAGR %	-61.73	-21.56	22.6	65.6	49.77
Inventory, 3 Yr. CAGR %	9.61	14.81	20.94	22.22	13.8
Net Property, Plant and Equip., 3 Yr. CAGR %	37.11	69.22	32.86	42	17.78
Total Assets, 3 Yr. CAGR %	66.37	63.16	49.49	10.26	6.04
Tangible Book Value, 3 Yr. CAGR %	117.94	118.14	100.26	5.21	0.86
Common Equity, 3 Yr. CAGR %	115.66	105.79	90.25	5.12	0.9
Cash From Operations, 3 Yr. CAGR %	36.83	-	-2	1.35	12.37
Capital Expenditures, 3 Yr. CAGR %	11.81	-	82.55	79.9	-35.53
Levered Free Cash Flow, 3 Yr. CAGR %	7.05	-	-36.2	-58.78	156.15
Unlevered Free Cash Flow, 3 Yr. CAGR %	6.32	-	-45.97	-37.43	215.36
Dividend Per Share, 3 Yr. CAGR %	-	-	28.92	-15.32	6.92
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	17.01	15.97	16.56	16.02
Gross Profit, 5 Yr. CAGR %	-	27.56	22.1	-11.8	18.59
EBITDA, 5 Yr. CAGR %	-	-	40.1	22.62	13.87
EBITA, 5 Yr. CAGR %	-	90.89	57.67	24.18	8.92
EBIT, 5 Yr. CAGR %	-	90.89	64.6	24.18	8.54
Earnings From Cont. Operations, 5 Yr. CAGR %	-	66.42	186.13	29.17	8.38
Net Income, 5 Yr. CAGR %	-	66.42	186.13	29.17	8.38
Normalized Net Income, 5 Yr. CAGR %	-	72.92	105.17	25.66	8.16
Diluted EPS Before Extra, 5 Yr. CAGR %	-	49.66	157.33	16.16	-2.05
Accounts Receivable, 5 Yr. CAGR %	-	-44.51	-26.71	1.02	27.89
Inventory, 5 Yr. CAGR %	-	8.03	13.89	15.91	18.8
Net Property, Plant and Equip., 5 Yr. CAGR %	-	35.09	43.49	51.1	23.4
Total Assets, 5 Yr. CAGR %	-	35.96	41.6	38.27	29.99
Tangible Book Value, 5 Yr. CAGR %	-	62.83	63.32	61.77	51.62
Common Equity, 5 Yr. CAGR %	-	61.43	62.16	56.22	47.08
Cash From Operations, 5 Yr. CAGR %	-	-	22.38	-	14.79
Capital Expenditures, 5 Yr. CAGR %	-	-	54.84	-	19.15
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-16.77	-	18.04
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-24.94	-	18.1
Dividend Per Share, 5 Yr. CAGR %	-	-	-	-	25.74